495 related articles for article (PubMed ID: 18990164)
1. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
Bolenz C; Shariat SF; Fernández MI; Margulis V; Lotan Y; Karakiewicz P; Remzi M; Kikuchi E; Zigeuner R; Weizer A; Montorsi F; Bensalah K; Wood CG; Roscigno M; Langner C; Koppie TM; Raman JD; Mikami S; Michel MS; Ströbel P
BJU Int; 2009 Feb; 103(3):302-6. PubMed ID: 18990164
[TBL] [Abstract][Full Text] [Related]
2. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
Remzi M; Haitel A; Margulis V; Karakiewicz P; Montorsi F; Kikuchi E; Zigeuner R; Weizer A; Bolenz C; Bensalah K; Suardi N; Raman JD; Lotan Y; Waldert M; Ng CK; Fernández M; Koppie TM; Ströbel P; Kabbani W; Murai M; Langner C; Roscigno M; Wheat J; Guo CC; Wood CG; Shariat SF
BJU Int; 2009 Feb; 103(3):307-11. PubMed ID: 18990163
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
[TBL] [Abstract][Full Text] [Related]
4. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
[TBL] [Abstract][Full Text] [Related]
5. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes.
Abe T; Shinohara N; Muranaka M; Sazawa A; Maruyama S; Osawa T; Harabayashi T; Kubota K; Matsuno Y; Shibata T; Toyada Y; Shinno Y; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
Eur J Surg Oncol; 2010 Nov; 36(11):1085-91. PubMed ID: 20832972
[TBL] [Abstract][Full Text] [Related]
6. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
Roscigno M; Brausi M; Heidenreich A; Lotan Y; Margulis V; Shariat SF; Van Poppel H; Zigeuner R
Eur Urol; 2011 Oct; 60(4):776-83. PubMed ID: 21798659
[TBL] [Abstract][Full Text] [Related]
7. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Kabbani W; Langner C; Guo CC; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
BJU Int; 2011 Oct; 108(8):1286-91. PubMed ID: 21332905
[TBL] [Abstract][Full Text] [Related]
8. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
9. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience.
Mason RJ; Kassouf W; Bell DG; Lacombe L; Kapoor A; Jacobsen N; Fairey A; Izawa J; Black P; Tanguay S; Chin J; So A; Lattouf JB; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Fradet Y; Rendon RA
Urology; 2012 Apr; 79(4):840-5. PubMed ID: 22365453
[TBL] [Abstract][Full Text] [Related]
10. Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
Youssef RF; Lotan Y; Sagalowsky AI; Shariat SF; Wood CG; Raman JD; Langner C; Zigeuner R; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
Int Braz J Urol; 2013; 39(5):614-21. PubMed ID: 24267122
[TBL] [Abstract][Full Text] [Related]
11. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Sun M; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Jan; 75(1):118-24. PubMed ID: 19864000
[TBL] [Abstract][Full Text] [Related]
12. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.
Bolenz C; Fernández MI; Trojan L; Hoffmann K; Herrmann E; Steidler A; Weiss C; Ströbel P; Alken P; Michel MS
BJU Int; 2009 Apr; 103(8):1040-6. PubMed ID: 18990139
[TBL] [Abstract][Full Text] [Related]
13. Lymph node density is a significant predictor of outcome in patients with oral cancer.
Gil Z; Carlson DL; Boyle JO; Kraus DH; Shah JP; Shaha AR; Singh B; Wong RJ; Patel SG
Cancer; 2009 Dec; 115(24):5700-10. PubMed ID: 19691095
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.
Roscigno M; Cozzarini C; Bertini R; Scattoni V; Freschi M; Da Pozzo LF; Briganti A; Gallina A; Capitanio U; Colombo R; Giorgio G; Montorsi F; Rigatti P
Eur Urol; 2008 Apr; 53(4):794-802. PubMed ID: 18207313
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
Fernández MI; Shariat SF; Margulis V; Bolenz C; Montorsi F; Suardi N; Remzi M; Wood CG; Roscigno M; Kikuchi E; Oya M; Zigeuner R; Langner C; Weizer A; Lotan Y; Koppie TM; Raman JD; Karakiewicz P; Bensalah K; Schultz M; Bernier P
Urology; 2009 Jan; 73(1):142-6. PubMed ID: 18845322
[TBL] [Abstract][Full Text] [Related]
16. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.
Dorin RP; Daneshmand S; Eisenberg MS; Chandrasoma S; Cai J; Miranda G; Nichols PW; Skinner DG; Skinner EC
Eur Urol; 2011 Nov; 60(5):946-52. PubMed ID: 21802833
[TBL] [Abstract][Full Text] [Related]
17. The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study.
Abe T; Shinohara N; Harabayashi T; Sazawa A; Ishikawa S; Kubota K; Matsuno Y; Osawa T; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Takeuchi I; Kumagai A; Mori T; Togashi M; Nonomura K
BJU Int; 2008 Aug; 102(5):576-80. PubMed ID: 18410428
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
Roscigno M; Shariat SF; Freschi M; Margulis V; Karakiewizc P; Suardi N; Remzi M; Zigeuner R; Bolenz C; Kikuchi E; Weizer A; Bensalah K; Sagalowsky A; Koppie TM; Raman J; Fernández M; Ströbel P; Kabbani W; Langner C; Wheat J; Guo CC; Kassouf W; Haitel A; Wood CG; Montorsi F
Urology; 2009 Nov; 74(5):1070-4. PubMed ID: 19883824
[TBL] [Abstract][Full Text] [Related]
19. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma.
Rao SR; Correa JJ; Sexton WJ; Pow-Sang JM; Dickinson SI; Lin HY; Spiess PE
BJU Int; 2012 Dec; 110(11 Pt B):E475-80. PubMed ID: 22564727
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
